TipRanks
United Health Products Inc (UEEC)
OTHER OTC:UEEC
US Market
UEEC
United Health Products
RESEARCH TOOLSreports

United Health Products (UEEC) Ratios

225 Followers

United Health Products Ratios

UEEC's free cash flow for Q2 2026 was $0.00. For the 2026 fiscal year, UEEC's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 0.02 0.03 0.12 0.08 0.03
Quick Ratio
 0.02 0.03 0.12 0.06 0.02
Cash Ratio
 <0.01 0.02 0.10 0.05 <0.01
Solvency Ratio
 -0.30 -0.64 -0.74 -1.31 -0.70
Operating Cash Flow Ratio
 -0.23 -0.30 -0.73 -1.13 -0.26
Short-Term Operating Cash Flow Coverage
 -0.52 -0.66 -35.84 -3.11 -0.90
Net Current Asset Value
$ -4.63M$ -4.09M$ -2.52M$ -1.85M$ -2.34M
Leverage Ratios
Debt-to-Assets Ratio
 9.40 6.46 4.10 2.76 1.96
Debt-to-Equity Ratio
 -0.52 -0.53 -0.45 -0.46 -0.33
Debt-to-Capital Ratio
 -1.10 -1.12 -0.83 -0.84 -0.50
Long-Term Debt-to-Capital Ratio
 -0.13 -0.07 -0.76 0.00 0.00
Financial Leverage Ratio
 -0.06 -0.08 -0.11 -0.17 -0.17
Debt Service Coverage Ratio
 -0.50 -1.13 -13.24 -3.04 -2.09
Interest Coverage Ratio
 -13.93 -11.27 -18.38 -20.88 -35.54
Debt to Market Cap
 0.22 0.15 0.08 0.01 0.01
Interest Debt Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Net Debt to EBITDA
 -2.43 -0.88 -0.50 -0.28 -0.42
Profitability Margins
Gross Profit Margin
0.00%0.00%0.00%0.00%50.28%
EBIT Margin
0.00%0.00%0.00%0.00%-4289.75%
EBITDA Margin
0.00%0.00%0.00%0.00%-4278.95%
Operating Profit Margin
0.00%0.00%0.00%0.00%-7472.10%
Pretax Profit Margin
0.00%0.00%0.00%0.00%-4500.00%
Net Profit Margin
0.00%0.00%0.00%0.00%-4500.00%
Continuous Operations Profit Margin
0.00%0.00%0.00%0.00%-4500.00%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
152.90%118.35%99.71%108.11%60.22%
Return on Assets (ROA)
-573.62%-842.87%-741.44%-921.60%-481.42%
Return on Equity (ROE)
35.90%68.86%81.91%153.03%81.72%
Return on Capital Employed (ROCE)
23.61%62.20%146.41%145.67%135.70%
Return on Invested Capital (ROIC)
44.06%123.11%153.89%261.09%203.45%
Return on Tangible Assets
-630.23%-912.92%-828.43%-1039.98%-537.29%
Earnings Yield
-13.68%-19.02%-15.16%-4.99%-2.58%
Efficiency Ratios
Receivables Turnover
 0.00 0.00 0.00 0.00 0.00
Payables Turnover
 <0.01 <0.01 <0.01 <0.01 0.01
Inventory Turnover
 0.00 0.00 0.00 0.14 0.54
Fixed Asset Turnover
 0.00 0.00 0.00 0.00 0.00
Asset Turnover
 0.00 0.00 0.00 0.00 0.11
Working Capital Turnover Ratio
 0.00 0.00 0.00 0.00 -0.02
Cash Conversion Cycle
 -186.38K -118.54K -65.40K -71.69K -23.89K
Days of Sales Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Inventory Outstanding
 0.00 0.00 0.00 2.52K 679.92
Days of Payables Outstanding
 186.38K 118.54K 65.40K 74.21K 24.57K
Operating Cycle
 0.00 0.00 0.00 2.52K 679.92
Cash Flow Ratios
Operating Cash Flow Per Share
 >-0.01 >-0.01 >-0.01 >-0.01 >-0.01
Free Cash Flow Per Share
 >-0.01 >-0.01 >-0.01 >-0.01 >-0.01
CapEx Per Share
 0.00 0.00 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 1.07
Dividend Paid and CapEx Coverage Ratio
 0.00 0.00 -298.68K -440.13K -15.30
Capital Expenditure Coverage Ratio
 0.00 0.00 -298.68K -440.13K -15.30
Operating Cash Flow Coverage Ratio
 -0.41 -0.58 -1.08 -2.80 -0.90
Operating Cash Flow to Sales Ratio
 0.00 0.00 0.00 0.00 -16.53
Free Cash Flow Yield
-9.13%-8.46%-9.05%-4.18%-1.01%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -7.27 -5.25 -6.56 -20.05 -38.80
Price-to-Sales (P/S) Ratio
 0.00 0.00 0.00 0.00 1.75K
Price-to-Book (P/B) Ratio
 -2.34 -3.62 -5.40 -30.68 -31.71
Price-to-Free Cash Flow (P/FCF) Ratio
 -10.96 -11.82 -11.05 -23.90 -99.16
Price-to-Operating Cash Flow Ratio
 -10.94 -11.82 -11.05 -23.90 -105.64
Price-to-Earnings Growth (PEG) Ratio
 -0.11 -0.18 0.25 -0.40 0.41
Price-to-Fair Value
 -2.34 -3.62 -5.40 -30.68 -31.71
Enterprise Value Multiple
 -13.40 -7.11 -7.49 -21.30 -41.22
Enterprise Value
 12.72M 16.01M 14.14M 53.29M 66.14M
EV to EBITDA
 -13.40 -7.11 -7.49 -21.30 -41.22
EV to Sales
 0.00 0.00 0.00 0.00 1.76K
EV to Free Cash Flow
 -13.38 -13.49 -11.83 -24.21 -100.18
EV to Operating Cash Flow
 -13.38 -13.49 -11.83 -24.21 -106.73
Tangible Book Value Per Share
 -0.02 -0.02 >-0.01 >-0.01 >-0.01
Shareholders’ Equity Per Share
 -0.02 -0.02 >-0.01 >-0.01 >-0.01
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 0.00 0.00 0.00 0.00 <0.01
Net Income Per Share
 >-0.01 -0.01 >-0.01 -0.01 >-0.01
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 1.49 1.08 1.06 1.05 1.05
Research & Development to Revenue
 0.00 0.00 0.00 0.00 16.66
SG&A to Revenue
 0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 12.89
Income Quality
 0.67 0.44 0.60 0.84 0.37
Currency in USD